EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer

This study aims to clarify the prognostic role of epidermal growth factor receptor (EGFR) mutations in plasma of non-small cell lung cancer (NSCLC) for resistance to tyrosine kinase inhibitor (TKI), in correlatio...

Source: Clinical and Translational Medicine - January 19, 2019 Category: Internal Medicine Authors: Thang Thanh Phan, Bich-Thu Tran, Son Truong Nguyen, Toan Trong Ho, Hang Thuy Nguyen, Vu Thuong Le and Anh Tuan Le Tags: Research Source Type: research